We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 371,490 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/7/2018 23:09 | dplewis1 "as you can see you can always guarantee a response from Hugh (except on the days when the share price is plummeting and he's on the phone to his broker" You just can't accept the truth as stated because it does not fit with your twisted agenda, you have to twist and put your own slant on things that I say. You really are a sick individual. | hughwilson | |
10/7/2018 23:04 | And to counter what the idiot dplewis1 likes to portray, that I am now pushing Nuvec. I have not mentioned them today at all but yes Nuvec news could drop at any time as the company state that they are looking to add further collaborations this year and that talks are being "progressed" | hughwilson | |
10/7/2018 23:02 | Gettingrichslow - as you can see you can always guarantee a response from Hugh (except on the days when the share price is plummeting and he's on the phone to his broker). Apparently I have a twisted agenda, which in my last post was to quote directly from Hugh himself to prove a point I was making.. Funny that you use the term groupthink - I used the same term when referring to the twitter group (there's some textbook confirmation bias going on with the likes of space robot, antman and mr wilson). They won't listen, but they won't go away either.. | dplewis1 | |
10/7/2018 22:56 | They'd be daft not too in my opinion and would add some confidence back to the shareprice | jamdan1 | |
10/7/2018 22:50 | jamdan1, I suggested to Nigel yesterday that a BOD share purchase would be well received, we will see what happens in that regard. | hughwilson | |
10/7/2018 22:37 | I wouldn't be surprised if the Bod have taken advantage of the current SharePrice. | jamdan1 | |
10/7/2018 22:18 | Good evening all. I've not posted on N4P before but I've been watching from afar because a colleague I work with has a significant investment and he asked me for my opinion a month ago. I'd like to make the following observations on this discussion board: 1. It is the most extreme example I've ever seen of 'groupthink' - with virtually everyone hyping each other up to get more and more convinced this company will take off. 2. I believe over 75% of contributors on here are deluded - there are some notable exceptions to this - people who have the capacity for independent thought and challenge the prevailing 'wisdom'. 3. If anyone is taken in by the laughable posts of 'Hugh Wilson' or 'Bricky' you need certifying. Sorry if that offends anyone but it needed saying. Do yourself a favour and sell up asap, then go and find a proper, quality investment. There are plenty out there. | gettingrichslow | |
10/7/2018 21:54 | Key point, will the "tweak" fall within the patent. If not its back to the dawing board. For me thats the real risk | zebbo | |
10/7/2018 21:40 | I don’t think I’ve ever disliked anyone I’ve never met as much as I dislike Hugh | eddie_yates | |
10/7/2018 21:37 | Well I’ve really enjoyed witnessing Hugh being destroyed by dplewis tonight | eddie_yates | |
10/7/2018 21:18 | Well my twisted mind saw the comment in parentheses ("which is not expected"), which changes the whole emphasis of the post. The overarching direction of your posting is to ignore the risks and overstate the upside. I don't need to provide evidence as it's there for all to see but a couple of examples might be:"Something is moving the price and that something is getting closer." Nice little unsubstantiated post to insinuate that a background 'in the know' buyer was accumulating. "The probability is that Nuvec is going to be huge." "Today marks the 8 week mark. Within the next two weeks the results of the Sildenafil trials will be out, not for me or Jo public but for someone in the know so the news will be in the share price long before they are announced. We have already seen steady large buys for the last few weeks trying to build a share without attracting attention..""That does not alter the argument for N4 at all. Their product is superior to the generics and will command a higher price and is fully patented. If Pfizer do not go down the JV route with N4 then from the time N4`s product hits the market they will be losing market share.""No matter how much Pfizer advertise their product, it is just a generic and no better than any other generic. N4`s sildenafil will be better performing and fully patented. Pfizer would be stupid not to do a JV."Those are just a few. It is not just my twisted mind that interprets that language as hugely overconfident in its nature. | dplewis1 | |
10/7/2018 20:13 | As for how easy the fix will be, even Nigel does not know the answer to that one yet but will update the market when he does. | hughwilson | |
10/7/2018 20:08 | "The company have stated that the reformulation may need to be tweaked" What I stated was fact NOT huge overconfidence, except in your twisted mind. | hughwilson | |
10/7/2018 19:34 | onzima, As I said before, the trial result was not as expected because you were dealing with a well tested drug. It was a surprise to everyone but that is a long way short of me saying that it was a done deal. The trial should have been successful but it wasn`t. That could easily be an easy fix but we now have to wait for the full data to know. Set that against | hughwilson | |
10/7/2018 19:28 | You said "The company have stated that the reformulation may need to be tweaked if it does not meet its profile(which is not expected)." Sounds pretty certain to me. And that was from your last but one post!! Stick to body building. | onzima | |
10/7/2018 19:22 | dplewis1 "The company have stated that the reformulation may need to be tweaked" Where except in your twisted mind did I say that the trial would be a certainty? All I can see is the way that you try to twist everything I say to suit your twisted and vile mind. | hughwilson | |
10/7/2018 19:09 | dplewis1 RNS from the 18th April. "The data gathered from the Trial will enable the Company to establish whether its reformulation has been sufficiently successful to allow N4 Pharma to prepare for a pre-IND meeting with the FDA towards the end of this year or whether further amendments to the reformulation may be required to optimise efficacy." My posts. 19th June "The company have stated that the reformulation may need to be tweaked if it does not meet its profile(which is not expected). The worst case scenario would be a re-run of the trial which would mean a delay and not a failure whereas success would mean its game on in a multi-billion dollar market" But of course, in your twisted mind that translates to success is nailed on. | hughwilson | |
10/7/2018 18:52 | dplewis1, I can not think of a single time that you have been right. Your mind is far too twisted for that. | hughwilson | |
10/7/2018 18:49 | Anyway, things to do. Boy did I make the right decision yesterday. | hughwilson |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions